Inhibikase Therapeutics, Inc. (IKT) Headquarters — Wilmington, Delaware

Headquarters

1000 N. West Street
Suite 1200
Wilmington, DE 19801

Tickerscape Verified 2026-08-17

All 26 public companies headquartered in Delaware

Exchange

Nasdaq

Sector

Medicine & Health

Industry

Biological Products, (No Diagnostic Substances)

Shares outstanding

139.54M (as of Aug 4, 2026)

Sector groupings are Tickerscape's own, derived from the company's SEC Standard Industrial Classification code — not GICS®, ICB® or any other licensed scheme, and they will disagree with those on some companies. How sectors are assigned.

View on the interactive map · Methodology

Informational purposes only — not investment advice. Headquarters location reflects the company's most recently recorded principal address.